Treatment of a patient with epidermodysplasia verruciformis carrying a novel EVER2 mutation with imiquimod

Cindy Berthelot, Mary C. Dickerson, Peter Rady, Qin He, Farhad Niroomand, Stephen K. Tyring, Amit G. Pandya

Research output: Contribution to journalArticle

42 Scopus citations


Epidermodysplasia verruciformis (EV) is a rare disorder characterized by widespread human papillomavirus infection and malignant transformation. EV may be caused by mutations of the genes EVER1 or EVER2, which are located on the EV1 locus, 17q25. We describe a patient with EV and a novel homozygous gene mutation of EVER2 gene who was treated successfully with topical imiquimod.

Original languageEnglish (US)
Pages (from-to)882-886
Number of pages5
JournalJournal of the American Academy of Dermatology
Issue number5
StatePublished - May 1 2007


ASJC Scopus subject areas

  • Dermatology

Cite this